Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $138.06 Million |
|---|---|
| Enterprise Value | $131.50 Million |
| Earnings per Share | $-0.04 |
| Beta | 0.82 |
| Outstanding Shares | 1,022,631,578 |
| P/E Ratio | -7.18 |
|---|---|
| PEG | -79.38 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.84 |
| Enterprise Value to EBIT | -1.89 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.12 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Pacific Edge Limited, a cancer diagnostics firm headquartered in Dunedin, New Zealand, and established in 2001, is dedicated to the research, development, and commercialization of advanced diagnostic and prognostic tools. These innovatio...